Anti-nausea drug Zofran being tested for its potential center rhythm side effects By Dr Ananya Mandal, MD AMERICA health regulators Food and Medication Administration are looking at the basic safety of GlaxoSmithKline’s anti-nausea drug Zofran generically referred to as ondansetron, to ascertain whether there is a potential risk of abnormal heart rhythm. Based on the FDA in a statement, the drug may increase the threat of developing abnormal changes in the electric activity of the center, resulting in a fatal center rhythm potentially. The FDA provides requested GSK to carry out a report on whether Zofran could prolong a patient’s QT interval, a measure of heart rhythm http://genericcialis-usa.com/cialis-vs-viagra.html .
Copyright 2006 Advisory Board Kaiser and Company Family Foundation. All rights reserved.. Antiretroviral drug discounts should be extended for countries categorized as ‘middle-income’ Pricing antiretroviral drugs and other lifesaving medicines based on a country’s gross national income per capita seems particularly arbitrary – – and even cruel – – considering that HIV-positive people often have incomes well beneath what might be regarded as a country’s ‘average’ income, Jorge Saavedra Lopez, general director of Mexico’s National Center for the Prevention and Control of HIV/AIDS, and AIDS Healthcare Basis President Michael Weinstein write in a San Jose Mercury Information opinion piece. Just countries classified as low-income predicated on GNI by the World Bank qualify for discounted antiretrovirals under the Accelerated Access Initiative, a public-private partnership that aims to increase access to essential medications in developing countries, regarding to Saavedra Weinstein and Lopez.